Vaccine Market - MENA
Market Statistics
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2.3 Billion
Market Size in 2033: USD 3.8 Billion
Market Growth Rate (CAGR) 2025-2033: 5.7%
According to IMARC Group's report titled "MENA Vaccine Market Report and Forecast 2024-2032," the market reached 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.7% during 2025-2033.
Download sample copy of the Report: https://www.imarcgroup.com/mena-vaccine-market/requestsample
MENA Vaccine Market Trends and Drivers
- Chronic Disease Prevalence: The spread of chronic conditions has increased demand for vaccines targeting diseases such as influenza, pneumonia, and hepatitis.
- Impact of COVID-19 Pandemic: The pandemic highlighted the importance of vaccines, accelerating their development, distribution, and adoption across the MENA region.
- Focus on Public Health: Increased emphasis on public health has led to investments in healthcare infrastructure and the development of national immunization schedules.
- Government and Global Organization Initiatives: Vaccination programs supported by governments and global organizations like WHO and UNICEF are ensuring widespread immunization coverage, especially among children.
- Rising Incidence of Vaccine-Preventable Diseases: The growing prevalence of diseases preventable through vaccination is a key factor behind market expansion.
- Awareness of Immunization: Increasing awareness of immunization as a critical tool for preventing infectious diseases is driving the MENA vaccine market.
- Adoption of Next-Generation Vaccine Technologies: The MENA vaccine market is witnessing a shift towards advanced technologies like mRNA and viral vector platforms, which offer higher efficacy and faster development timelines.
- Focus on Vaccine Independence: Governments in the region are promoting self-reliance by fostering partnerships with international manufacturers and investing in local biotechnology companies to develop indigenous vaccines.
- Innovations in Vaccine Delivery: Needle-free devices and thermostable formulations are improving vaccine accessibility, particularly in remote and cold chain-limited areas.
- Private Sector Involvement: The private sector is increasingly collaborating with public health agencies to enhance vaccine distribution and coverage.
- Rise of Combination Vaccines: Growing interest in combination vaccines, which provide immunity against multiple diseases in a single dose, is simplifying immunization schedules and improving compliance.
- Outlook: These drivers and trends are expected to propel the MENA vaccine market during the forecast period.
MENA Vaccine Industry Segmentation:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest MENA vaccine market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.
Product Type Insights:
- Multivalent Vaccine
- Monovalent Vaccine
Treatment Type Insights:
- Preventive Vaccine
- Therapeutic Vaccine
Technology Insights:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others
Route of Administration Insights:
- Intramuscular and Subcutaneous Administration
- Oral Administration
- Others
Patient Type Insights:
- Pediatric
- Adult
Indication Insights:
- Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
- Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Institutional Sales
- Others
End User Insights:
- Hospitals
- Clinics
- Vaccination Centers
- Academic and Research Institutes
- Others
Country Insights:
- Saudi Arabia
- Turkey
- Israel
- United Arab Emirates
- Egypt
- Iran
- Iraq
- Qatar
- Algeria
- Kuwait
- Morocco
- Oman
- Others
Request for customization: https://www.imarcgroup.com/request?type=report&id=16112&flag=C
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comments